As of March 2024 Myriad Genetics has a market cap of $1.91 Billion. This makes Myriad Genetics the world's 4199th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.91 B | 11.68% |
2023 | $1.71 B | 45.92% |
2022 | $1.17 B | -46.65% |
2021 | $2.20 B | 47.82% |
2020 | $1.49 B | -26.5% |
2019 | $2.02 B | -4.67% |
2018 | $2.12 B | -10.52% |
2017 | $2.37 B | 108.51% |
2016 | $1.14 B | -63.09% |
2015 | $3.09 B | 26.86% |
2014 | $2.43 B | 56.96% |
2013 | $1.55 B | -29.95% |
2012 | $2.21 B | 24.88% |
2011 | $1.77 B | -13.82% |
2010 | $2.05 B | -18.12% |
2009 | $2.51 B | -18.4% |
2008 | $3.08 B | 49.62% |
2007 | $2.05 B | 64.9% |
2006 | $1.24 B | 53.44% |
2005 | $0.81 B | 17.69% |
2004 | $0.69 B | 98.13% |
2003 | $0.34 B | -11.49% |
2002 | $0.39 B | -68.45% |
2001 | $1.25 B |
On Mar 28th, 2024 the market cap of Myriad Genetics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | $197.22 B | 10,192.64% | ๐บ๐ธ USA |
Exact Sciences EXAS | $12.53 B | 554.26% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $16.47 B | 760.01% | ๐บ๐ธ USA |
Biocept
BIOC | $1.14 M | -99.94% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | $9.77 B | 410.20% | ๐บ๐ธ USA |